fbpx Opioids | NDARC - National Drug and Alcohol Research Centre

Opioids

An open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence

image - CoLAB

Retaining patients in buprenorphine treatment is essential in maximising treatment outcomes and minimising mortality risk. Delivery of treatment via novel depot buprenorphine products has the potential to enhance patient adherence and retention in treatment.

Project Status: 
Current